Minireviews
Copyright ©The Author(s) 2022.
Artif Intell Med Imaging. Apr 28, 2022; 3(2): 21-32
Published online Apr 28, 2022. doi: 10.35711/aimi.v3.i2.21
Table 2 Studies on artificial intelligence using endoscopic ultrasound to diagnose pancreatic ductal adenocarcinoma
Ref.Clinical questionTraining set (number of subjects)Validation set (number of subjects)AI instrument AUROCAccuracySensitivity Specificity
Udristoiu et al[84], 2021Detecting focal pancreatic masses in four EUS imaging modalities65CNN and Long Short-term Memory models0.9797.6%98.1%96.7%
Tonozuka et al[83], 2021Detecting PDAC in patients with normal pancreas/Chronic pancreatitis92CNN0.924NA90.2%74.9%
Marya et al[78], 2021Differentiate AIP from PDAC, chronic pancreatitis and other pancreatic diseases336124CNN0.976NA95%90%
Kuwahara et al[77], 2019Predicting malignancy in IPMN50CNN0.9894%95.7%92.6%
Ozkan et al[80], 2016Differentiating pancreatic cancer from healthy pancreas260 images 72 images ANNNA87.5%83.3%93.3%
Saftoiu et al[81], 2015Differentiate pancreatic cancer from chronic pancreatitis11725ANNNANA94.6%94.4%
Zhu et al[86], 2013Differentiating pancreatic cancer from chronic pancreatitis. 194194SVMNA94.2%96.3%93.4%
Saftoiu et al[82], 2012Diagnosis of focal pancreatic lesions 258 patients ANN0.9484.27%87.59%82.94%
Zhang et al[85], 2010Differentiate pancreatic cancer from non-tumorous tissue108108SVMNA97.98%94.3%99.45%
Saftoiu et al[20], 2008 cancerDifferentiate normal pancreas, chronic pancreatitis, pancreatic cancer, and neuroendocrine tumors68Neural network0.847 (for PDAC vs chronic pan-creatitis)86.1% (for PDAC vs chronic pan-creatitis)93.8% (for PDAC vs chronic pan-creatitis)63.6% (for PDAC vs chronic pan-creatitis)
Das et al[19], 2008Differentiating pancreatic adenocarcinoma from non-neoplastic tissue (includes normal pancreas and chronic pancreatitis)160159ANN0.93NA93%92%
Norton et al[79], 2001Differentiate malignancy from pancreatitis35MLNA80%100%50%